Skeletal Muscle clinical trials

Explore recruiting skeletal muscle clinical trials.

Recruiting skeletal muscle studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Skeletal Muscle trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Does human skeletal muscle possess an epigenetic memory of testosterone

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Adult Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

Netherlands, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Effect of Roxadustat on Cardiometabolism

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Skeletal muscle-derived cell implantation for the treatment of fecal incontinence: a phase III, randomized, controlled, double blind, two-armed clinical study.

Germany, Bulgaria, Spain, Poland, Sweden, Austria +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

The rimegePant in RElation to obeSiTy in mIGrainE study

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 1/2, first-in-human, two-part, open-label clinical trial of intravenous administration of CTL-002 given as monotherapy and/or in combination with an anti-PD-1 checkpoint inhibitor in subjects with advanced-stage, relapsed/refractory solid tumors.

Germany, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Skeletal Muscle trials by city

Skeletal Muscle in Toronto Skeletal Muscle in Vancouver Skeletal Muscle in Montreal Skeletal Muscle in Calgary Skeletal Muscle in Edmonton Skeletal Muscle in Ottawa Skeletal Muscle in Winnipeg Skeletal Muscle in Quebec City Skeletal Muscle in Hamilton Skeletal Muscle in Kitchener Skeletal Muscle in London Skeletal Muscle in Halifax Skeletal Muscle in New York Skeletal Muscle in Los Angeles Skeletal Muscle in Chicago Skeletal Muscle in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease